---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-031819"
form_type: "8-K"
ticker: "FHTX"
cik: "0001822462"
company_name: "Foghorn Therapeutics Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T05:02:35.099400+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Foghorn Therapeutics stockholders elect four Class II directors, ratify Deloitte as auditor

## Summary
- Elected Stuart Duty, Neil J. Gallagher, Adrian Gottschalk, and Ian F. Smith as Class II directors for three-year terms.
- Votes for nominees ranged from 30.9M (Ian F. Smith) to 34.6M (Neil J. Gallagher); 8.68M broker non-votes.
- Ratified Deloitte & Touche LLP as independent auditor for FY2025 with 43.34M votes for, 16,978 against.
- Total shares present at meeting: 43,369,822 out of 55,721,340 outstanding; all proposals approved.

## SEC filing metadata
- accession: 0001628280-25-031819
- form_type: 8-K
- ticker: FHTX
- cik: 0001822462
- company_name: Foghorn Therapeutics Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/0001628280-25-031819-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822462/000162828025031819/fhtx-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-031819
- JSON: https://secwatch.observer/filing/0001628280-25-031819.json
- Plain text: https://secwatch.observer/filing/0001628280-25-031819.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.